111 related articles for article (PubMed ID: 12410192)
21. Vibration treatment in cerebral palsy: A randomized controlled pilot study.
Ruck J; Chabot G; Rauch F
J Musculoskelet Neuronal Interact; 2010 Mar; 10(1):77-83. PubMed ID: 20190383
[TBL] [Abstract][Full Text] [Related]
22. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
23. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
24. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
26. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
27. Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease.
Sbrocchi AM; Forget S; Laforte D; Azouz EM; Rodd C
Pediatr Int; 2010 Oct; 52(5):754-61. PubMed ID: 20524999
[TBL] [Abstract][Full Text] [Related]
28. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
[TBL] [Abstract][Full Text] [Related]
29. Osteopenia in cerebral palsy.
Shaw NJ; White CP; Fraser WD; Rosenbloom L
Arch Dis Child; 1994 Sep; 71(3):235-8. PubMed ID: 7979497
[TBL] [Abstract][Full Text] [Related]
30. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial.
Chen L; Huang H; Xi H; Xie Z; Liu R; Jiang Z; Zhang F; Liu Y; Chen D; Wang Q; Wang H; Ren Y; Zhou C
Cell Transplant; 2010; 19(2):185-91. PubMed ID: 20350360
[TBL] [Abstract][Full Text] [Related]
31. Osteopenia in children with cerebral palsy can be treated with oral alendronate.
Paksu MS; Vurucu S; Karaoglu A; Karacalioglu AO; Polat A; Yesilyurt O; Unay B; Akin R
Childs Nerv Syst; 2012 Feb; 28(2):283-6. PubMed ID: 21928064
[TBL] [Abstract][Full Text] [Related]
32. Dietary considerations in osteopenia in tube-fed nonambulatory children with cerebral palsy.
Duncan B; Barton LL; Lloyd J; Marks-Katz M
Clin Pediatr (Phila); 1999 Mar; 38(3):133-7. PubMed ID: 10349077
[TBL] [Abstract][Full Text] [Related]
33. The use of pamidronate in three children with renal disease.
Sellers E; Sharma A; Rodd C
Pediatr Nephrol; 1998 Nov; 12(9):778-81. PubMed ID: 9874327
[TBL] [Abstract][Full Text] [Related]
34. Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy.
Sees JP; Sitoula P; Dabney K; Holmes L; Rogers KJ; Kecskemethy HH; Bachrach S; Miller F
J Pediatr Orthop; 2016 Mar; 36(2):193-7. PubMed ID: 25757207
[TBL] [Abstract][Full Text] [Related]
35. The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy.
Moon SJ; An YM; Kim SK; Kwon YS; Lee JE
Korean J Pediatr; 2017 Dec; 60(12):403-407. PubMed ID: 29302265
[TBL] [Abstract][Full Text] [Related]
36. Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.
Harcke HT; Stevenson KL; Kecskemethy HH; Bachrach SJ; Grissom LE
Pediatr Radiol; 2012 Jan; 42(1):76-81. PubMed ID: 21877116
[TBL] [Abstract][Full Text] [Related]
37. Pamidronate treatment of pediatric fracture patients on chronic steroid therapy.
Acott PD; Wong JA; Lang BA; Crocker JF
Pediatr Nephrol; 2005 Mar; 20(3):368-73. PubMed ID: 15690187
[TBL] [Abstract][Full Text] [Related]
38. Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.
Almeida Da Silva LC; Kaymaz B; Hori Y; Montufar Wright PE; Rogers KJ; Trionfo A; Howard JJ; Bowen JR; Shrader MW; Miller F
J Pediatr Orthop B; 2024 Jul; 33(4):407-410. PubMed ID: 37811568
[TBL] [Abstract][Full Text] [Related]
39. Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series.
Sholas MG; Tann B; Gaebler-Spira D
J Pediatr Orthop; 2005; 25(3):326-31. PubMed ID: 15832148
[TBL] [Abstract][Full Text] [Related]
40. How safe and effective is the use of bisphosphonates in the treatment of osteoporosis in children with cerebral palsy? A Cochrane Review summary with commentary.
Arman S
Dev Med Child Neurol; 2022 Mar; 64(3):286-288. PubMed ID: 35040137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
